| Followers | 604 |
| Posts | 24107 |
| Boards Moderated | 3 |
| Alias Born | 12/06/2009 |
Monday, May 18, 2020 11:24:05 PM
$MYMX ~ Mymetics has started a Covid-19 vaccine development project based on Mymetics’ virosome vaccine carrier platform, which will evaluate different rationally designed SARS-CoV-2 antigens for an effective and safe virosome-based Covid-19 vaccine
Baylor College of Medicine in Texas has developed SARS-CoV and SARS-CoV-2 recombinant proteins and has extensive expertise developing protein-based vaccines from discovery through clinical testing
Baylor and Mymetics will collaborate to evaluate the Baylor SARS recombinant protein antigens linked to Mymetics’ virisomes in preclinical studies with the aim to identify and select the most efficacious and safe formulations to take forward a virosome-based COVID-19 vaccine through product and clinical development
79 million in the float! Huge DD~ only .036 ~!!!
NEWS RELEASE:
https://apnews.com/1c0328b682359d47948ed627c626adc4
https://www.mymetics.com/media-center/mymetics/
DD:
https://www.bcm.edu/news/infectious-diseases/covid-19-vaccine-baylor-texas-childrens
$MYMX BOARD:
https://investorshub.advfn.com/boards/board.aspx?board_id=1365
Baylor College of Medicine in Texas has developed SARS-CoV and SARS-CoV-2 recombinant proteins and has extensive expertise developing protein-based vaccines from discovery through clinical testing
Baylor and Mymetics will collaborate to evaluate the Baylor SARS recombinant protein antigens linked to Mymetics’ virisomes in preclinical studies with the aim to identify and select the most efficacious and safe formulations to take forward a virosome-based COVID-19 vaccine through product and clinical development
79 million in the float! Huge DD~ only .036 ~!!!
NEWS RELEASE:
https://apnews.com/1c0328b682359d47948ed627c626adc4
https://www.mymetics.com/media-center/mymetics/
DD:
https://www.bcm.edu/news/infectious-diseases/covid-19-vaccine-baylor-texas-childrens
$MYMX BOARD:
https://investorshub.advfn.com/boards/board.aspx?board_id=1365
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
